The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemotherapy plus radiotherapy (CT-RT) versus RT alone for patients with anaplastic oligodendroglioma: Long-term results of the RTOG 9402 phase III study.
J. Gregory Cairncross
No relevant relationships to disclose
Meihua Wang
No relevant relationships to disclose
Edward G. Shaw
No relevant relationships to disclose
Robert B. Jenkins
No relevant relationships to disclose
Bernd W. Scheithauer
No relevant relationships to disclose
David Brachman
No relevant relationships to disclose
Jan C. Buckner
No relevant relationships to disclose
Karen L. Fink
No relevant relationships to disclose
Luis Souhami
No relevant relationships to disclose
Normand Laperriere
No relevant relationships to disclose
Walter J. Curran
No relevant relationships to disclose
Minesh P. Mehta
No relevant relationships to disclose